Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
4.210
-0.260 (-5.82%)
At close: Jan 9, 2026, 4:00 PM EST
4.180
-0.030 (-0.71%)
After-hours: Jan 9, 2026, 4:46 PM EST
Moolec Science Revenue
Moolec Science had revenue of $2.64M in the quarter ending December 31, 2024, with 948.32% growth. This brings the company's revenue in the last twelve months to $7.83M, up 170.36% year-over-year. In the fiscal year ending June 30, 2024, Moolec Science had annual revenue of $5.63M with 521.53% growth.
Revenue (ttm)
$7.83M
Revenue Growth
+170.36%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.63M | 4.72M | 521.53% |
| Jun 30, 2023 | 905.05K | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MLEC News
- 3 days ago - Moolec Science Announces Effectiveness of Share Consolidation - Accesswire
- 9 days ago - Moolec Receives Staff Determination Letter and Provides Update on Nasdaq Listing Compliance Status - Accesswire
- 9 days ago - Moolec Science SA Announces the Implementation of a Share Consolidation of Its Ordinary Shares, Par Value U.S.$0.10 Per Share (the "Shares") - Accesswire
- 4 weeks ago - Moolec Science Scales GLASO U.S. Platform With Record 2025 Campaign and Expansion Into Nutrition & Supplements Market - Accesswire
- 6 weeks ago - Moolec Receives Nasdaq Determination Letter - Accesswire
- 3 months ago - Top 3 Defensive Stocks Which Could Rescue Your Portfolio In Q4 - Benzinga
- 4 months ago - Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment - Accesswire
- 7 months ago - Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein - Accesswire